Frequently Asked Questions (FAQs)

Telemedicine Partner

Telehealth services provided by:

CareValidate
4575 Webb Bridge Rd,
Alpharetta, GA 30005

844.357.3601

carevalidate.com

Lion MD:
A trusted team of nationwide medical professionals led by Dr. Ana Lisa Carr MD (NPI: 1689841744) and Dr. Kelly Tenbrink MD (NPI: 1346482684).

Supporting Medical Team:
Dr. HirenKimar Italia MD (NPI: 1487815387)
Dr. David Mansour DO (NPI: 1689164949)

Pharmacy Partners

Belmar Pharmacy (Arizona)
6597 N 92nd St, Suite 105
Scottsdale, AZ 85260
800.525.9473
http://belmarpharmasolutions.com/

Strive Pharmacy
21143 Hawthorne Blvd, Suite 305
Torrance, CA 90503
855.405.5993
http://strivepharmacy.com/

Epiq Scripts
625 Herndon Ave, Suite D
Clovis, CA 93612
833.654.3553
http://epiqscripts.com/

Casa Pharma Rx
12855 Capricorn St
Stafford, TX 77477
877.937.6868
http://casapharmarx.com/

Yes! We accept both FSA and HSA cards.

It's important to contact your healthcare provider right away if you experience any symptoms such as a lump or swelling in your neck, hoarseness, difficulty in swallowing, or shortness of breath, as these may be indicators of thyroid cancer. Semaglutide should not be used if you or any family members have had medullary thyroid carcinoma (MTC), or if you have a condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). The effectiveness and safety of using semaglutide in combination with other weight loss products are yet to be confirmed. It is vital to share your full medical history with your healthcare provider. This includes informing them if you have had conditions like Type 1 or Type 2 diabetes, thyroid cancer, pancreatitis, kidney disease, diabetic retinopathy, depression, or any history of suicidal thoughts or behaviors.

Your delivery will be timely, following a thorough assessment by our medical team and the issuance of your prescription, typically within 5 to 7 days. Our process ensures a consistent supply of medication every month for your continued progress.

Please refer to your instructions included with the medication. If you encounter any issues or have questions, please consult your doctor through our support platform. Medications are taken orally, topically or via injection. Please refer to our educational videos for How-to for guidance on subcutaneous injection.

When a drug is in shortage, compounders can prepare a compounded version of that drug if they meet certain requirements in the Federal Food, Drug, and Cosmetic (FD&C) Act.

You can check for drug shortages on the FDA website.

Pharmacies in the CareGLP network comply strictly with all the regulatory standards established by:

• State boards of pharmacy, which regulate all 503A pharmacies

• FDA, which has oversight for the safety of all active pharmaceutical ingredients

• DEA, that oversees the controlled substances sometimes used in compounded preparations

• USP Convention, that issues practice standards ensuring quality and safety of medications and food

• USP General Chapter <795> provides guidelines for the prevention of contamination and potency variance, preparation process, beyond-use dates, and stability for non-sterile compounding

Pharmacies in the CareGLP network run quality assurance and quality control checks for every batch of compounded semaglutide prescribed to patients.

Some of these steps include but are not limited to:

• Reviewing and confirming the Active Pharmaceutical Ingredient (API) Certificate of Analysis for all semaglutide base lots, which are received from FDA-registered manufacturers;

• Storing the verified API frozen and sealed until use;

• Compounding with the API under aseptic processes to produce specific lots (vials);

• Holding the vials of compounded semaglutide in quarantine (representative samples are taken for testing);

• Using independent third-party laboratories to test the potency, sterility and endotoxicity of each lot of compounded semaglutide (among other criteria);

• Reviewing the results of these tests and, if satisfactory, releasing the validated vials from quarantine for dispensing;

• Assigning each compounded lot a unique lot number and BUD (Beyond Use Date), which is added to the container and is tracked electronically;

• Scanning the lot information on the product at the time of dispensing, which ties a particular lot number to the patient’s file.